Search results
Stock Market Crash Warning: Don't Get Caught Holding These 3 Cathie Wood Stocks
InvestorPlace· 2 days agoFor a time, Cathie Wood was the hottest investor on Wall Street. Ark Invest was bringing in billions of dollars in new assets under management. A February report found that in aggregate, her ...
3 Growth Stocks You'll Kick Yourself for Not Buying Today
InvestorPlace· 1 day agoGrowth stocks epitomize the attraction of equity investing due to their strong potential and ability to generate substantial returns. When referring to these stocks, those companies with leadership ...
Midday movers: Carvana and Qualcomm rise; DoorDash, Fastly, Zillow fall
Investing.com· 3 days agoMidday movers: Carvana and Qualcomm rise; DoorDash, Fastly, Zillow fall
J.P. Morgan downgrades Metagenomi over Moderna deal termination (NASDAQ:MGX)
Seeking Alpha· 2 days agoJ.P. Morgan has lowered its rating of Metagenomi (NASDAQ:MGX) to neutral, citing the recent...
Recent Insider Activity Suggests Potential Gains for Moderna Inc
Knox Daily· 4 days agoA total of 2.61 million shares were traded, compared to the trading of 3.41 million shares in the previous session. Levels Of Support And Resistance For MRNA Stock ...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 4 days agoPfizer PFE is scheduled to release its first-quarter earnings report before the opening bell on May...
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Zacks via Yahoo Finance· 1 day agoOver the past six months, shares of MRNA have risen 46.27%. (See the last biotech stock roundup...
Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
Zacks via Yahoo Finance· 2 days agoOver the past six months, shares of MRNA have risen 46.27%. (See the last biotech stock roundup...
Stocks to Watch Thursday: Carvana, NIO, Qualcomm, Peloton
The Wall Street Journal· 2 days ago**Peloton Interactive (PTON)**: The fitness-equipment maker said Chief Executive Barry McCarthy was...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 2 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...